CALR and neoplasm: Increased immunogenic tumor cell death may contribute to maturation and tumor antigen-presentation activity of DCs resulting from release of damage-associated molecular patterns (DAMPs) molecules from tumor cells, such as chaperone protein calreticulin (CRT), high mobility group box-1 protein (HMGB1), and heat shock proteins (HSPs).